RecruitingPhase 1 / Phase 2NCT07061574
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Sponsor: City of Hope Medical Center
Indianapolis, IN · +10 more sites
Type 1 Diabetes clinical trials in Indianapolis, IN
19 recruiting type 1 diabetes studies with a site in Indianapolis, IN.
RecruitingPhase 2NCT07187531
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Sponsor: SAb Biotherapeutics, Inc.
Indianapolis, IN · +21 more sites
RecruitingNot applicableNCT07287943
To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.
Sponsor: Viral N. Shah
Indianapolis, IN
RecruitingNot applicableNCT07663136
Finding Immune Nascent Type 1 Diabetes
Sponsor: Indiana University
Indianapolis, IN
RecruitingNot applicableNCT07282639
App-Based Certified Diabetes Education Therapy (AB-CDE)
Sponsor: Oregon Health and Science University
Indianapolis, IN · +5 more sites
RecruitingPhase not listedNCT02734277
Type 1 Diabetes Extension Study
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Indianapolis, IN · +11 more sites
RecruitingPhase 1 / Phase 2NCT06783309
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Sponsor: COUR Pharmaceutical Development Company, Inc.
Indianapolis, IN · +44 more sites
RecruitingPhase 2NCT07142252
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Indianapolis, IN · +13 more sites
RecruitingPhase 2NCT05414409
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
Sponsor: Heba M. Ismail
Indianapolis, IN
RecruitingPhase 2NCT07224321
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Sponsor: Mannkind Corporation
Indianapolis, IN · +9 more sites
RecruitingNot applicableNCT07579702
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Sponsor: Insulet Corporation
Indianapolis, IN · +10 more sites
RecruitingPhase 1 / Phase 2NCT06524960
Denosumab for Type 1 Diabetes
Sponsor: City of Hope Medical Center
Indianapolis, IN · +2 more sites
RecruitingPhase 2NCT05762107
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Sponsor: Zucara Therapeutics Inc.
Indianapolis, IN · +37 more sites
RecruitingPhase not listedNCT06481904
Registry for Stage 2 Type 1 Diabetes
Sponsor: Sanofi
Indianapolis, IN · +36 more sites
RecruitingPhase not listedNCT06401577
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics
Sponsor: Milton S. Hershey Medical Center
Indianapolis, IN · +12 more sites
RecruitingPhase not listedNCT05197920
Diabetes RElated to Acute Pancreatitis and Its Mechanisms
Sponsor: Milton S. Hershey Medical Center
Indianapolis, IN · +12 more sites
RecruitingPhase not listedNCT00097292
TrialNet Pathway to Prevention of T1D
Sponsor: University of South Florida
Indianapolis, IN · +16 more sites
Not yet recruitingNot applicableNCT06783504
Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2
Sponsor: Indiana University
Indianapolis, IN
Not yet recruitingPhase 3NCT07670650
PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study
Sponsor: University of Florida
Indianapolis, IN · +3 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.